Position
Quantbot Technologies LP in Theravance Biopharma, Inc.
Back to the book · All holders of TBPH
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark −$18K$18.71 → $16.23
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 19.3K | $362K | — | — | — | 0.0% |
| Q1 2026 | 7.27K | $118K | $16.23 | −$18K | −$226K | 0.0% |